Patents by Inventor Terry J. Amiss

Terry J. Amiss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180051330
    Abstract: Provided are methods of amplifying nucleic acids. The methods include combining a nucleic acid sample, a known amount of one or more competitive internal standard nucleic acids, and one or more amplification primers adapted to amplify one or more nucleic acids of interest present in the nucleic acid sample and the one or more competitive internal standard nucleic acids. The nucleic acid sample, competitive internal standard nucleic acids, and amplification primers are combined in a reaction mixture under conditions sufficient to amplify the one or more nucleic acids of interest and the one or more competitive internal standard nucleic acids. Aspects of the present disclosure further include compositions and kits that find use in practicing embodiments of the methods.
    Type: Application
    Filed: March 29, 2016
    Publication date: February 22, 2018
    Inventors: Terry J. Amiss, Nicholas Herrmann, Richard Lee Kelley, Frances Poyen Tong, Eileen Snowden
  • Publication number: 20150018641
    Abstract: A device for sensing analyte concentration, and in particular glucose concentration, in vivo or in vitro is disclosed. A sensing element is attached to the distal end of an optical conduit, and comprises at least one binding protein adapted to bind with at least one target analyte. The sensing element further comprises at least one reporter group that undergoes a luminescence change with changing analyte concentrations. Optionally, the optical conduit and sensing element may be housed within a cannulated bevel.
    Type: Application
    Filed: July 1, 2013
    Publication date: January 15, 2015
    Applicant: Becton, Dickinson and Company
    Inventors: Javier Alarcon, Kristin Weidemaier, Terry J. Amiss, John D. DeNuzzio, Christopher C. Herdman, Ross W. Jacobson, J. Bruce Pitner, Douglas B. Sherman
  • Publication number: 20150004629
    Abstract: The present invention relates to functional, modified glucose-galactose binding proteins (GGBPs), that have a greater melting temperature (Tm) than a reference GGBP. The present invention also relates to biological sensors, e.g., glucose sensors, comprising these thermostable GGBPs. The present invention also relates to nucleic acids encoding these thermostable GGBPs.
    Type: Application
    Filed: June 6, 2014
    Publication date: January 1, 2015
    Applicant: Becton, Dickinson and Company
    Inventors: Terry J. Amiss, Erin M. Gill, Douglas Byron Sherman
  • Patent number: 8778635
    Abstract: The present invention relates to functional, modified glucose-galactose binding proteins (GGBPs), that have a greater melting temperature (Tm) than a reference GGBP. The present invention also relates to biological sensors, e.g., glucose sensors, comprising these thermostable GGBPs. The present invention also relates to nucleic acids encoding these thermostable GGBPs.
    Type: Grant
    Filed: July 24, 2013
    Date of Patent: July 15, 2014
    Assignee: Becton, Dickinson and Company
    Inventors: Terry J. Amiss, Erin M. Gill, Douglas Byron Sherman
  • Patent number: 8623639
    Abstract: The present invention relates to functional, modified glucose-galactose binding proteins (GGBPs), that have a greater melting temperature (Tm) than a reference GGBP. The present invention also relates to biological sensors, e.g., glucose sensors, comprising these thermostable GGBPs. The present invention also relates to nucleic acids encoding these thermostable GGBPs.
    Type: Grant
    Filed: April 20, 2007
    Date of Patent: January 7, 2014
    Assignee: Becton, Dickinson and Company
    Inventors: Terry J. Amiss, Erin M. Gill, Douglas B. Sherman
  • Publication number: 20130302908
    Abstract: The present invention relates to functional, modified glucose-galactose binding proteins (GGBPs), that have a greater melting temperature (Tm) than a reference GGBP. The present invention also relates to biological sensors, e.g., glucose sensors, comprising these thermostable GGBPs. The present invention also relates to nucleic acids encoding these thermostable GGBPs.
    Type: Application
    Filed: July 24, 2013
    Publication date: November 14, 2013
    Inventors: Terry J. Amiss, Erin M. Gill, Douglas Byron Sherman
  • Publication number: 20110184259
    Abstract: A device for sensing analyte concentration, and in particular glucose concentration, in vivo or in vitro is disclosed. A sensing element is attached to the distal end of an optical conduit, and comprises at least one binding protein adapted to bind with at least one target analyte. The sensing element further comprises at least one reporter group that undergoes a luminescence change with changing analyte concentrations. Optionally, the optical conduit and sensing element may be housed within a cannulated bevel.
    Type: Application
    Filed: August 23, 2010
    Publication date: July 28, 2011
    Inventors: Javier Alarcon, Kristin Weidemaier, Terry J. Amiss, John D. DeNuzzio, Christopher C. Herdman, Ross W. Jacobson, J. Bruce Pitner, Douglas B. Sherman, Steven Keith
  • Patent number: 7851593
    Abstract: The invention is directed to compositions of mutated binding proteins containing reporter groups, analyte biosensor devices derived therefrom, and their use as analyte biosensors both in vitro and in vivo.
    Type: Grant
    Filed: February 12, 2004
    Date of Patent: December 14, 2010
    Assignee: Becton, Dickinson and Company
    Inventors: Helen Vivian Hsieh, J. Bruce Pitner, Terry J. Amiss, Colleen M. Nycz, Douglas B. Sherman, David J. Wright
  • Patent number: 7792561
    Abstract: A device for sensing analyte concentration, and in particular glucose concentration, in vivo or in vitro is disclosed. An optical conduit, preferably an optical fiber has an optical system at the proximal end of the optical conduit. A sensing element is attached to the distal end of the optical conduit, and comprises at least one binding protein adapted to bind with at least one target analyte. The sensing element further comprises at least one reporter group that undergoes a luminescence change with changing analyte concentrations. Optionally, the sensing element includes reference groups with luminescence properties that are substantially unchanged by variations in the analyte concentrations.
    Type: Grant
    Filed: August 16, 2007
    Date of Patent: September 7, 2010
    Assignee: Becton, Dickinson and Company
    Inventors: Javier Alarcon, Kristin Weidemaier, Terry J. Amiss, John D. Denuzzio, Christopher C. Herdman, Ross Wayne Jacobson, J. Bruce Pitner, Douglas B. Sherman
  • Patent number: 7496392
    Abstract: A device for sensing analyte concentration, and in particular glucose concentration, in vivo or in vitro is described. An optical conduit, preferably an optical fiber, has an optical system at the proximal end of the optical conduit. A sensing element is attached to the distal end of the optical conduit, and may include at least one binding protein adapted to bind with at least one target analyte. The sensing element further may also include at least one reporter group that undergoes a luminescence change with changing analyte concentrations. Optionally, the sensing element includes reference groups with luminescence properties that are substantially unchanged by variations in the analyte concentrations.
    Type: Grant
    Filed: November 26, 2003
    Date of Patent: February 24, 2009
    Assignee: Becton, Dickinson and Company
    Inventors: Javier Alarcón, Kristin Weidemaier, Terry J. Amiss, John D. DeNuzzio, Christopher C. Herdman, Ross Wayne Jacobson, J. Bruce Pitner, Douglas B. Sherman
  • Publication number: 20080198358
    Abstract: A device for sensing analyte concentration, and in particular glucose concentration, in vivo or in vitro is disclosed. An optical conduit, preferably an optical fiber has an optical system at the proximal end of the optical conduit. A sensing element is attached to the distal end of the optical conduit, and comprises at least one binding protein adapted to bind with at least one target analyte. The sensing element further comprises at least one reporter group that undergoes a luminescence change with changing analyte concentrations. Optionally, the sensing element includes reference groups with luminescence properties that are substantially unchanged by variations in the analyte concentrations.
    Type: Application
    Filed: August 16, 2007
    Publication date: August 21, 2008
    Inventors: Javier Alarcon, Kristin Weidemaier, Terry J. Amiss, John D. Denuzzio, Christopher C. Herdman, Ross Wayne Jacobson, J. Bruce Pitner, Douglas B. Sherman
  • Patent number: 6855556
    Abstract: The invention is directed to compositions of mutated binding proteins containing reporter groups, analyte biosensor devices derived there from, and their use as analyte biosensor both in vitro and in vivo.
    Type: Grant
    Filed: January 4, 2002
    Date of Patent: February 15, 2005
    Assignee: Becton, Dickinson and Company
    Inventors: Terry J. Amiss, Colleen M. Nycz, J. Bruce Pitner, Douglas B. Sherman, David J. Wright
  • Publication number: 20030134346
    Abstract: The invention is directed to compositions of mutated binding proteins containing reporter groups, analyte biosensor devices derived there from, and their use as analyte biosensor both in vitro and in vivo.
    Type: Application
    Filed: January 4, 2002
    Publication date: July 17, 2003
    Inventors: Terry J. Amiss, Colleen M. Nycz, J. Bruce Pitner, Douglas B. Sherman, David J. Wright